Therapeutic intervension for post-craniotomy headache

Therapeutic intervension for post-craniotomy headache - Therapeutic intervension for post-craniotomy headache

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000040778

Enrollment

Registered

2020-06-16

Start date

2020-06-16

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

post-craniotomy headache

Interventions

prescription of Neurotropine 4T x2 From the occurence of post-craniotomy headache to the remission.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Post-craniotomy headache

Exclusion criteria

Exclusion criteria: Chronic headache case. Post-craniotomy complication case. The patient who could not evaluate their headache because of consciousness disturbance or dysphagia.

Design outcomes

Primary

Measure	Time frame
frequency and intensity of post-craniotomy headache at 1 and 3 months after neurotropine intake	—

Secondary

Measure	Time frame
Patient factor(primary disease, age, sex) Post-craniotomy headache(occurence period, frequency, intensity) Craniotomy(surgery, skin incision, dural closure, craniectomy, cranioplasty)	—

Countries

Japan

Contacts

Public ContactYasushi Shibata

University of Tsukuba Neurosurgery

yshibata@md.tsukuba.ac.jp+81292312371

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026